Developer docs
API playgroundTry for free, no card

Search company profiles

Redi.Health

Full company profile

uuid0000m5q

Namestring
Redi.Health
Legal namestring
Redi Health
Websiteurl
redi.health
Company typeenum
Private
Founded yearint
2021
Descriptiontext

Redi.Health is a Columbus, Ohio-based healthcare technology company founded in 2021 that operates a B2B SaaS platform connecting pharmaceutical manufacturers to patients through a mobile and web-based interface. The company's core offering is a patient access and support platform that combines a proprietary patient acquisition network (Redi Network), co-built Patient Support Programs (PSPs), real-time analytics dashboards, and integrations across pharmacies, EHR systems, hub services, and copay programs. The platform is purpose-built for pharma commercialization workflows, with MLR and PRC compliance and flexible brand guideline rendering embedded into the product architecture.

The company serves two sides of the market: pharmaceutical manufacturers (primary paying customers) seeking to increase patient acquisition, enrollment in support programs, and therapy adherence/sustainment, and patients with chronic conditions who use the free Redi mobile and web app for medication reminders, refill management, co-pay assistance, and care coordination. Revenue is generated through enterprise SaaS subscriptions paid by life sciences companies, with pricing not publicly disclosed and contracts structured as multi-product, multi-year co-innovation partnerships.

Redi.Health was founded by Luke Buchanan (CEO), Jaimin Gandhi (CTO), Kyle Grimslid (CSO), and Nate Rehm (CRO), and has raised approximately $25 million across four funding rounds led by Mutual Capital Partners, Refinery Ventures, and Blue Heron Capital. The company has 11-50 employees, is venture-backed and privately held, operates exclusively in the United States, and reports outcomes including a 27% lift in prescription fills, 80% on-time refill rate, 10% decrease in first-fill abandonment, and 61% six-month therapy sustainment.

Short descriptiontext

Redi.Health is a healthcare technology company that operates a B2B SaaS platform connecting pharmaceutical manufacturers to patients through a mobile and web app, driving patient acquisition, enrollment in support programs, and medication adherence for life sciences clients.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersColumbus, United States
HQ citystring
Columbus
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
patient support platform, digital health SaaS, medication adherence software, pharma patient access, patient engagement solutions
Industry2 codes
PRIMARYHLACAEAJ
Adherence, Reminders & Engagement Automation (Medication/Follow-up)
Healthcare & Life Sciences/Digital Health & Health IT/Patient Engagement, CRM & Experience Platforms
SECONDARYHLACAKAF
Medication Adherence, Reminders & Patient Support
Healthcare & Life Sciences/Digital Health & Health IT/ePrescribing, Medication Management & Pharmacy IT
NAICS code1 code
  • Scientific Research and Development Services5417
SIC code1 code
  • Services-Health Services8000
Product category
Digital Health Patient Support Platform
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1B2B SaaS Platform for Life Sciences
TypeSubscription Recurring
Description

Platform-as-a-service model connecting pharmaceutical manufacturers to patients. Life sciences companies pay for patient support program capabilities that drive new patient acquisition and medication sustainment.

redi.health
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure
GTM typeB2B
B2B
Offering typeSoftware
Software
Core offering1 text field

Redi Health provides a B2B patient access and support platform that connects pharmaceutical manufacturers to patients across the therapy journey. Through a proprietary patient acquisition network, integrations with pharmacies, EHRs, hub services, and copay programs, and a patient-facing mobile/web application with real-time analytics, the platform drives new patient acquisition, medication adherence, and therapy sustainment for life sciences clients. Patients access the platform free of charge; life sciences companies subscribe to the platform-as-a-service to optimize their Patient Support Programs.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 7 values shown
  • 27% lift in prescription fills compared to patients not using Redi platform
+6 more records
Product overview1 text field

Redi.Health offers a unified patient access and support platform consisting of the core Redi Health Platform, a patient-facing mobile and web application, and integrated program features including the Redi Network for patient acquisition, Patient Support Programs (PSPs), real-time analytics dashboards, and copay smoothing programs. The platform connects pharmaceutical manufacturers to patients through pharmacies, EHR systems, hub services, and copay programs, enabling patient acquisition, medication adherence, and therapy sustainment across the treatment journey.

Product and service2 records
1Redi Health Platform
CategoryPatient Support Platform (Life Sciences SaaS)
Description

A B2B patient access and support platform for pharmaceutical manufacturers that drives new patient acquisition and medication sustainment across therapy journeys, integrating pharmacies, EHRs, hub services, and copay programs with real-time PSP analytics and MLR/PRC-compliant brand rendering.

2Redi Patient Mobile & Web App
CategoryPatient Engagement Mobile/Web Application
Description

A free patient-facing mobile and web application that helps users manage and track health conditions and medication schedules, with prescription refill tracking, savings and co-pay assistance, message center notifications, and connections to pharmacies, providers, insurance, and support resources.

Scale indicator7 records

Each record includes

Type, Value, Description, Source

Partnership6 partners
1GoodRx
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Healthcare partnership formed to improve patient outcomes. GoodRx provides prescription pricing and discount services integrated with Redi's patient support platform.

finsmes.com
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Healthcare partnership to support medication delivery and pharmacy integration, aiming to improve patient outcomes in 2023.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Healthcare partnership with major diagnostic laboratory company to support patient access and integrated care coordination.

Strategic tierCoreTypeTechnology or Integration
Description

Integrated pharmacy network enabling prescription tracking, refill management, and seamless patient experience across pharmacy touchpoints.

Strategic tierCoreTypeTechnology or Integration
Description

Electronic Health Record integrations enabling data connectivity and seamless patient identification within existing clinical workflows.

Strategic tierCoreTypeTechnology or Integration
Description

Integration with patient hub services including prior authorization, co-pay programs, and hub operations to streamline patient support.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Public digital health company that delivers patient and provider engagement solutions to life sciences, with a strong focus on therapy initiation, affordability, and adherence — directly overlapping Redi's patient support program and copay assistance use cases.

TypeBroad incumbent
Description

Global life sciences services and technology giant offering patient engagement, hub, and commercial analytics capabilities as part of a much broader portfolio; competes for the same pharma PSP and patient engagement budgets as Redi.

TypeBroad incumbent
Description

Dominant SaaS provider to life sciences across CRM, data, and patient programs. Veeva's patient and consumer engagement offerings compete with Redi for pharma brand team wallet share, especially on regulated patient communication workflows.

TypeDirect peer
Description

Specialty hub services and patient support provider for biopharma, including prior authorization, copay, and adherence programs — directly comparable to Redi's hub-integrated PSP and therapy sustainment offering.

TypeDirect peer
Description

Specialty therapy initiation and patient access platform connecting pharma manufacturers, providers, and patients — overlapping with Redi's patient acquisition, prior auth, and adherence solutions for specialty medications.

TypeBroad incumbent
Description

Large patient services and hub provider for specialty pharmaceuticals, part of Cencora; competes for the same patient support and adherence program engagements that Redi targets with pharma manufacturers.

TypeDirect peer
Description

Digital medication adherence platform for patients with chronic conditions; comparable to Redi's patient-facing mobile experience for medication reminders, refill management, and ongoing engagement.

TypeDirect peer
Description

Medication adherence analytics and intervention platform serving health plans and pharma, focused on predicting and improving persistency — adjacent to Redi's analytics-driven adherence and sustainment capabilities.

9GoodRx
TypeOthers
Description

Consumer-facing prescription pricing, discount, and engagement platform that is both a partner of Redi (copay integration) and a competitor in patient affordability and engagement for pharma-sponsored programs.

TypeEmerging player
Description

Patient intake, engagement, and clinical workflow platform with growing life sciences sponsorship capabilities — competes for pharma dollars seeking to engage patients around the point of prescription and during therapy.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration5 records

Each record includes

Title, Type, Description, Source

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds4 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors7 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Redi.Health

Digital Health Patient Support Platformredi.health

Redi.Health is a healthcare technology company that operates a B2B SaaS platform connecting pharmaceutical manufacturers to patients through a mobile and web app, driving patient acquisition, enrollment in support programs, and medication adherence for life sciences clients.

What Redi.Health does

Redi.Health is a Columbus, Ohio-based healthcare technology company founded in 2021 that operates a B2B SaaS platform connecting pharmaceutical manufacturers to patients through a mobile and web-based interface. The company's core offering is a patient access and support platform that combines a proprietary patient acquisition network (Redi Network), co-built Patient Support Programs (PSPs), real-time analytics dashboards, and integrations across pharmacies, EHR systems, hub services, and copay programs. The platform is purpose-built for pharma commercialization workflows, with MLR and PRC compliance and flexible brand guideline rendering embedded into the product architecture.

The company serves two sides of the market: pharmaceutical manufacturers (primary paying customers) seeking to increase patient acquisition, enrollment in support programs, and therapy adherence/sustainment, and patients with chronic conditions who use the free Redi mobile and web app for medication reminders, refill management, co-pay assistance, and care coordination. Revenue is generated through enterprise SaaS subscriptions paid by life sciences companies, with pricing not publicly disclosed and contracts structured as multi-product, multi-year co-innovation partnerships.

Redi.Health was founded by Luke Buchanan (CEO), Jaimin Gandhi (CTO), Kyle Grimslid (CSO), and Nate Rehm (CRO), and has raised approximately $25 million across four funding rounds led by Mutual Capital Partners, Refinery Ventures, and Blue Heron Capital. The company has 11-50 employees, is venture-backed and privately held, operates exclusively in the United States, and reports outcomes including a 27% lift in prescription fills, 80% on-time refill rate, 10% decrease in first-fill abandonment, and 61% six-month therapy sustainment.

Redi.Health firmographics

Firmographics
Name
Redi.Health
Legal name
Redi Health
Website
https://redi.health
Company type
Private
Founded year
2021
Operating status
Operating
Headcount range
51–100 employees
Short description
Redi.Health is a healthcare technology company that operates a B2B SaaS platform connecting pharmaceutical manufacturers to patients through a mobile and web app, driving patient acquisition, enrollment in support programs, and medication adherence for life sciences clients.
Ownership category
akta.pro rank

Redi.Health industry classification

Industry
Product category
Digital Health Patient Support Platform
NAICS
Scientific Research and Development Services (5417)
SIC
Services-Health Services (8000)
akta.pro industry
PRIMARYHLACAEAJ
Adherence, Reminders & Engagement Automation (Medication/Follow-up)
Healthcare & Life Sciences/Digital Health & Health IT/Patient Engagement, CRM & Experience Platforms
SECONDARYHLACAKAF
Medication Adherence, Reminders & Patient Support
Healthcare & Life Sciences/Digital Health & Health IT/ePrescribing, Medication Management & Pharmacy IT

Keywords

  • Patient support platform
  • Digital health SaaS
  • Medication adherence software
  • Pharma patient access
  • Patient engagement solutions

Where Redi.Health is headquartered

Location

Headquarters

HQ city
Columbus
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Redi.Health business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure

Revenue model

  1. B2B SaaS Platform for Life Sciences: Platform-as-a-service model connecting pharmaceutical manufacturers to patients. Life sciences companies pay for patient support program capabilities that drive new patient acquisition and medication sustainment.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels5 records

Redi.Health product offering

Product offering

Core offering

Redi Health provides a B2B patient access and support platform that connects pharmaceutical manufacturers to patients across the therapy journey. Through a proprietary patient acquisition network, integrations with pharmacies, EHRs, hub services, and copay programs, and a patient-facing mobile/web application with real-time analytics, the platform drives new patient acquisition, medication adherence, and therapy sustainment for life sciences clients. Patients access the platform free of charge; life sciences companies subscribe to the platform-as-a-service to optimize their Patient Support Programs.

Product overview

Redi.Health offers a unified patient access and support platform consisting of the core Redi Health Platform, a patient-facing mobile and web application, and integrated program features including the Redi Network for patient acquisition, Patient Support Programs (PSPs), real-time analytics dashboards, and copay smoothing programs. The platform connects pharmaceutical manufacturers to patients through pharmacies, EHR systems, hub services, and copay programs, enabling patient acquisition, medication adherence, and therapy sustainment across the treatment journey.

Differentiator

Problem solved

Functional benefit

Products and services

  • Redi Health Platform A B2B patient access and support platform for pharmaceutical manufacturers that drives new patient acquisition and medication sustainment across therapy journeys, integrating pharmacies, EHRs, hub services, and copay programs with real-time PSP analytics and MLR/PRC-compliant brand rendering.
  • Redi Patient Mobile & Web App A free patient-facing mobile and web application that helps users manage and track health conditions and medication schedules, with prescription refill tracking, savings and co-pay assistance, message center notifications, and connections to pharmacies, providers, insurance, and support resources.

Quantifiable outcome

  • 27% lift in prescription fills compared to patients not using Redi platform
  • +6 more outcomes

Companies that use Redi.Health

Customer profile

Named customers1 record

Segments2 records

Ideal customer profiles1 record

Redi.Health technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration5 records

Feature5 records

Redi.Health partnerships and signals

Strategic signal

Partnerships

Six partnerships are on record, tiered minor and core.

  • GoodRxminorStrategic or Co-development PartnerHealthcare partnership formed to improve patient outcomes. GoodRx provides prescription pricing and discount services integrated with Redi's patient support platform.
  • ScriptDropminorStrategic or Co-development PartnerHealthcare partnership to support medication delivery and pharmacy integration, aiming to improve patient outcomes in 2023.
  • LabcorpminorStrategic or Co-development PartnerHealthcare partnership with major diagnostic laboratory company to support patient access and integrated care coordination.
  • PharmaciescoreTechnology or IntegrationIntegrated pharmacy network enabling prescription tracking, refill management, and seamless patient experience across pharmacy touchpoints.
  • EHR SystemscoreTechnology or IntegrationElectronic Health Record integrations enabling data connectivity and seamless patient identification within existing clinical workflows.
  • Hub ServicescoreTechnology or IntegrationIntegration with patient hub services including prior authorization, co-pay programs, and hub operations to streamline patient support.

Scale indicators7 records

Recent moves6 records

Expansion highlights5 records

Redi.Health competitors and assessment

Company assessment

Direct peers

  • OptimizeRx: Public digital health company that delivers patient and provider engagement solutions to life sciences, with a strong focus on therapy initiation, affordability, and adherence — directly overlapping Redi's patient support program and copay assistance use cases.
  • CareMetx: Specialty hub services and patient support provider for biopharma, including prior authorization, copay, and adherence programs — directly comparable to Redi's hub-integrated PSP and therapy sustainment offering.
  • AssistRx: Specialty therapy initiation and patient access platform connecting pharma manufacturers, providers, and patients — overlapping with Redi's patient acquisition, prior auth, and adherence solutions for specialty medications.
  • Medisafe: Digital medication adherence platform for patients with chronic conditions; comparable to Redi's patient-facing mobile experience for medication reminders, refill management, and ongoing engagement.
  • RxAnte: Medication adherence analytics and intervention platform serving health plans and pharma, focused on predicting and improving persistency — adjacent to Redi's analytics-driven adherence and sustainment capabilities.

Broad incumbents

  • IQVIA (Patient Engagement / Orchestrated Customer Engagement): Global life sciences services and technology giant offering patient engagement, hub, and commercial analytics capabilities as part of a much broader portfolio; competes for the same pharma PSP and patient engagement budgets as Redi.
  • Veeva Systems: Dominant SaaS provider to life sciences across CRM, data, and patient programs. Veeva's patient and consumer engagement offerings compete with Redi for pharma brand team wallet share, especially on regulated patient communication workflows.
  • Lash Group (AmerisourceBergen / Cencora): Large patient services and hub provider for specialty pharmaceuticals, part of Cencora; competes for the same patient support and adherence program engagements that Redi targets with pharma manufacturers.

Others

  • GoodRx: Consumer-facing prescription pricing, discount, and engagement platform that is both a partner of Redi (copay integration) and a competitor in patient affordability and engagement for pharma-sponsored programs.

Emerging players

  • Phreesia: Patient intake, engagement, and clinical workflow platform with growing life sciences sponsorship capabilities — competes for pharma dollars seeking to engage patients around the point of prescription and during therapy.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Redi.Health social profiles

Digital presence

Redi.Health financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Redi.Health leadership team

Management profile

Number of profiles

Profiles1 record

Redi.Health funding detail

Funding detail

Funding overview

Funding rounds4 records

Investors7 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Redi.Health M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Redi.Health

What does Redi.Health do?

Redi Health provides a B2B patient access and support platform that connects pharmaceutical manufacturers to patients across the therapy journey. Through a proprietary patient acquisition network, integrations with pharmacies, EHRs, hub services, and copay programs, and a patient-facing mobile/web application with real-time analytics, the platform drives new patient acquisition, medication adherence, and therapy sustainment for life sciences clients. Patients access the platform free of charge; life sciences companies subscribe to the platform-as-a-service to optimize their Patient Support Programs.

Is Redi.Health a public or private company?

Redi.Health is a private company. It is classified as venture growth investor backed and is currently operating.

When was Redi.Health founded?

Redi.Health was founded in 2021. It employs 51 to 100 people.

Where is Redi.Health based?

Redi.Health is headquartered in Columbus, United States, in the North America region.

How does Redi.Health make money?

One revenue line is on record: B2B SaaS Platform for Life Sciences.

Who are Redi.Health's main competitors?

Direct peers on record are OptimizeRx, CareMetx, AssistRx, Medisafe and RxAnte. Broad incumbents are IQVIA (Patient Engagement / Orchestrated Customer Engagement), Veeva Systems and Lash Group (AmerisourceBergen / Cencora). GoodRx is listed as an others. Phreesia is listed as an emerging player.

Does Redi.Health have an API?

No public API is recorded for Redi.Health.

What industry is Redi.Health in?

Redi.Health's product category is Digital Health Patient Support Platform. Its primary akta.pro industry code is HLACAEAJ, Adherence, Reminders & Engagement Automation (Medication/Follow-up), with a secondary code of HLACAKAF, Medication Adherence, Reminders & Patient Support. Its NAICS code is 5417 and its SIC code is 8000.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
AxiosColumbus, Ohio startup scene includes green energy tech, college sports paymentsFive Central Ohio startups are highlighted: Redi Health, Power to Hydrogen, Trace, Clarametyx, and Five Star Fans. Redi Health raised $14 million, Power to Hydrogen $18 million, Clarametyx $33 million, and Trace $2 million. The startups span health tech, green energy, AR, and college sports payments.Pulse 2.0Redi Health Raises $140 Million In Round Led By Blue Heron CapitalBlue Heron Capital led a $14 million Series B round for Redi Health, with participation from Refinery Ventures, Mutual Capital Partners, Rev1 Ventures, and M25. Redi Health will use the funds to develop new products, expand its patient network, and improve patient support for complex medications. The company cites a 70% non-adherence rate and $600 billion in annual losses in traditional patient support programs.WebrazziSağlık yönetimi platformu Redi Health, 14 milyon dolar yatırım aldıRedi Health, Blue Heron Capital liderliğindeki B serisi yatırım turunda 14 milyon dolar finansman sağladı. Şirket, elde ettiği bu yatırımı ürün geliştirme ve Ar-Ge faaliyetlerine yönlendirmeyi planlıyor.FinSMEsRedi Health Raises $14M in Series B FundingRedi Health, a Columbus, OH-based digital health startup, raised $14M in Series B funding led by Blue Heron Capital. The company will use the funds to develop new products, expand its patient network, and accelerate growth. Blue Heron OA Collaborative member Jim Clair joined the board.Business Wire BlogBlue Heron Capital Invests in Redi Health to Modernize Patient Support Services and Expand Healthcare AccessBlue Heron Capital led a $14M Series B round in Redi Health, a digital health platform for patient support. The funds will develop new products and expand its patient network, aiming to address a 70% non-adherence rate and $600B annual industry losses.PR NewswireRedi Health Lands $14 Million Investment to Continue Improving Patient Health Outcomes by Connecting Pharma, Providers, and Patients in One PlatformRedi Health closed $14 million in Series B funding led by Blue Heron Capital, with participation from North Coast Ventures and existing investors. The company will use the funds to develop new products and expand its network, addressing a 70% non-adherence rate in pharmaceutical patient support programs.American City Business JournalsColumbus health IT startup Redi Health raises $14M after more than doubling businessRedi Health, a Columbus health IT startup, raised $14 million in a Series B round led by Blue Heron Capital. The company, which has 25 employees, will use the funds to expand its network and reach patients early, having grown adoption of its chronic disease app by over 100% last year.Vbdata健康管理平台提供商Redi Health获得1400万美元B轮融资,以继续改善患者的健康状况-动脉橙Health management platform provider Redi Health secured $14 million in Series B funding led by Blue Heron Capital, with participation from North Coast Ventures and other existing investors. The company intends to utilize this capital to develop new products, expand its network, and accelerate growth within the digital health sector.Venture Capital Access OnlineRedi Health Lands $14 Million Investment to Continue Improving Patient Health Outcomes by Connecting Pharma, Providers, and Patients in One PlatformRedi Health has closed a $14 million Series B funding round led by Blue Heron Capital, with participation from several other venture firms. The company intends to use the capital to expand its digital health platform that connects pharmaceutical manufacturers, healthcare providers, and patients to improve medication adherence. This investment underscores Redi Health's position in the digital health sector as it seeks to modernize outdated patient support programs.VC News DailyRedi Health Lands $14 Million InvestmentRedi Health has closed a $14 million Series B funding round. The investment was led by Blue Heron Capital, with participation from North Coast Ventures and existing investors Refinery Ventures, Mutual Capital Partners, Rev1 Ventures, and M25.